Cargando…

Prognostic factor analysis in 325 patients with Graves’ disease treated with radioiodine therapy

INTRODUCTION: (131)I therapy is a choice for Graves’ hyperthyroidism. Several factors that affect the success of (131)I treatment in Graves’ disease (GD) patients have been put forward. The aim of this retrospective study was to evaluate the factors influencing the success of (131)I therapy and the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Danrong, Xue, Jianjun, Ma, Wenxia, Liu, Furong, Fan, Yameng, Rong, Jie, Yang, Aimin, Yu, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728590/ https://www.ncbi.nlm.nih.gov/pubmed/29040161 http://dx.doi.org/10.1097/MNM.0000000000000770

Ejemplares similares

Potential role of poly (ADP-ribose) polymerase in delayed cerebral vasospasm following subarachnoid hemorrhage in rats
por: Fan, Yameng, et al.
Publicado: (2019)

Curcumin induced autophagy anticancer effects on human lung adenocarcinoma cell line A549
por: Liu, Furong, et al.
Publicado: (2017)

Validation and Assessment of Three Methods to Estimate 24-h Urinary Sodium Excretion from Spot Urine Samples in High-Risk Elder Patients of Stroke from the Rural Areas of Shaanxi Province
por: Ma, Wenxia, et al.
Publicado: (2017)

Radioiodine therapy and Graves’ disease – Myths and reality
por: Plazinska, Maria Teresa, et al.
Publicado: (2020)

Radioiodine Therapy of Graves' Disease and the Uptake Paradox
por: Malapure, Sumeet Suresh, et al.
Publicado: (2020)

Radioiodine Therapy-Induced Conversion of Toxic Adenoma to Graves’ Disease
por: Rehman, Anis, et al.
Publicado: (2020)

Radioiodine therapy in patients with Graves’ disease and the effects of prior carbimazole therapy
por: Karyampudi, Arun, et al.
Publicado: (2014)

Post-radioiodine management of patients with Graves' disease
por: Collins, K, et al.
Publicado: (2012)

A mathematical model of optimized radioiodine-131 therapy of Graves' hyperthyroidism
por: Doi, Suhail AR, et al.
Publicado: (2001)

Acute effects of radioiodine therapy on the voice and larynx of basedow-graves patients
por: Isolan-Cury, Roberta Werlang, et al.
Publicado: (2015)

Radioiodine Thyroid Ablation in Graves’ Hyperthyroidism: Merits and Pitfalls
por: Nwatsock, J. F., et al.
Publicado: (2012)

The effect of radioiodine treatment on the characteristics of TRAb in Graves’ disease
por: Fang, Ya, et al.
Publicado: (2021)

Myopathy Associated with Acute Hypothyroidism following Radioiodine Therapy for Graves Disease in an Adolescent
por: Benavides, Valeria C., et al.
Publicado: (2010)

Graves disease following radioiodine therapy for toxic adenoma: Clinical case report
por: Shen, Guohua, et al.
Publicado: (2017)

Pattern of presentation of Graves’ disease and response to radioiodine therapy in South African men
por: Onimode, Yetunde Ajoke, et al.
Publicado: (2018)

Prognostic Value of (99m)Tc-Pertechnetate Thyroid Scintigraphy in Radioiodine Therapy in a Cohort of Chinese Graves' Disease Patients: A Pilot Clinical Study
por: Hou, Haifeng, et al.
Publicado: (2015)

Focus on radioiodine-131 biokinetics: the influence of methylprednisolone on intratherapeutic effective half-life of (131)I during radioiodine therapy of Graves’ disease
por: Happel, C., et al.
Publicado: (2021)

Should radioiodine now be first line treatment for Graves’ disease?
por: Okosieme, Onyebuchi E., et al.
Publicado: (2020)

Graves Disease Induced by Radioiodine Therapy for Toxic Nodular Goiter: A Case Report
por: Yürekli, Yakup, et al.
Publicado: (2015)

Time course of Graves’ orbitopathy after total thyroidectomy and radioiodine therapy for thyroid cancer
por: Louvet, Camille, et al.
Publicado: (2016)

Synergic radiosensitization of sinomenine hydrochloride and radioiodine on human papillary thyroid carcinoma cells
por: Zhao, Aomei, et al.
Publicado: (2021)

Thymic Involution After Radioiodine Therapy for Graves Disease: Relationships With Serum Thyroid Hormones and TRAb
por: Jinguji, Megumi, et al.
Publicado: (2017)

Worsening of pretibial myxedema following radioiodine treatment for hyperthyroid Graves’ disease
por: Thewjitcharoen, Yotsapon, et al.
Publicado: (2023)

SAT-417 Personalized Treatment Planning for Radioiodine Therapy of Graves’ Disease;The Collar Therapy Indicator(CoTI)
por: Santhanam, Prasanna, et al.
Publicado: (2020)

Machine learning identifies baseline clinical features that predict early hypothyroidism in patients with Graves’ disease after radioiodine therapy
por: Duan, Lian, et al.
Publicado: (2022)

Primary autoimmune thrombocytopenia and co-existing Graves’ disease: Role of radioiodine-131
por: Jung, Rayamajhi Sampanna, et al.
Publicado: (2014)

Comparison of Fixed versus Calculated Activity of Radioiodine for the Treatment of Graves Disease in Adults
por: Canto, Abigail U., et al.
Publicado: (2016)

Radioiodine treatment for graves’ disease: a 10-year Australian cohort study
por: Fanning, Erin, et al.
Publicado: (2018)

Serum Thyroid Hormone Balance in Levothyroxine Monotherapy-Treated Patients with Atrophic Thyroid After Radioiodine Treatment for Graves' Disease
por: Ito, Mitsuru, et al.
Publicado: (2019)

Changes in Thyrotropin Receptor Antibody Levels Following Total Thyroidectomy or Radioiodine Therapy in Patients with Refractory Graves' Disease
por: Kim, Jinyoung, et al.
Publicado: (2021)

Extremely high doses of radioiodine required for treatment of Graves’ hyperthyroidism: a case report
por: Neto, Arnaldo Moura, et al.
Publicado: (2009)

Changes in the Properties of the Thyrotropin Receptor Antibody in Patients with Graves’ Disease after Radioiodine Treatment
por: Cho, Bo Youn, et al.
Publicado: (1990)

Analysis of risk factors of rapid thyroidal radioiodine-131 turnover in Graves’ disease patients
por: Zhang, Ruiguo, et al.
Publicado: (2017)

To Treat or Not to Treat: The Role of Adjuvant Radioiodine Therapy in Thyroid Cancer Patients
por: Carballo, Marilee, et al.
Publicado: (2012)

Reviewers BJCVS 32.5
Publicado: (2017)

Health Tract No. 325: The Ego
Publicado: (1868)

Beneficial effect of low-dose radioiodine ablation for Graves’ orbitopathy: results of a retrospective study
por: Lanzolla, Giulia, et al.
Publicado: (2021)

A Systematic Review and Meta-Analysis of the Relationship Between the Radiation Absorbed Dose to the Thyroid and Response in Patients Treated with Radioiodine for Graves' Disease
por: Taprogge, Jan, et al.
Publicado: (2021)

Therapeutic response and long-term outcome of differentiated thyroid cancer with pulmonary metastases treated by radioiodine therapy
por: Yang, Jing, et al.
Publicado: (2017)

Multivariate Regression Analysis Identifying Predictors of Patient Satisfaction with Multifocal IOLs: +4.00/+4.00 vs +3.25/+3.25 vs +3.25/EDOF
por: Bucci, Frank A
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4vg33k02m2q129jj52gou8u8oj